These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7387825)

  • 21. Dextran or warfarin: which drug to follow heparin?
    Nolan TR; Crumbley AJ; Grady ED; Rosen AJ
    J Med Assoc Ga; 1979 Nov; 68(11):969-70. PubMed ID: 501235
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fibrinolytic treatment of large vein thrombosis].
    Skóra K; Szydlowski Z; Samplawska-Maj B; Dorobisz A
    Pol Tyg Lek; 1974 Jun; 29(24):1039-40. PubMed ID: 4845081
    [No Abstract]   [Full Text] [Related]  

  • 23. [Low-molecular-weight heparin without oral anticoagulants for the treatment of deep vein thrombosis].
    Alonso Martínez JL; Abínzano Guillén ML; Urbieta Echezarreta MA; Annichérico Sánchez FJ; Fernández Ladrón V; García Sanchotena JL
    An Med Interna; 2008 Jan; 25(1):4-8. PubMed ID: 18377187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oral anticoagulants: warfarin or acenocumarol?].
    Roncalés FJ
    Med Clin (Barc); 2008 Jun; 131(3):98-100. PubMed ID: 18590624
    [No Abstract]   [Full Text] [Related]  

  • 25. Warfarin resistance in a patient with short bowel syndrome.
    Brophy DF; Ford SL; Crouch MA
    Pharmacotherapy; 1998; 18(3):646-9. PubMed ID: 9620117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation.
    Falk RH
    J Am Coll Cardiol; 2004 Oct; 44(8):1567-9. PubMed ID: 15489086
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety and effectiveness of low dose oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulation.
    Poli D; Antonucci E; Lombardi A; Gensini GF; Abbate R; Prisco D
    Haematologica; 2003 Feb; 88(2):237-8. PubMed ID: 12604423
    [No Abstract]   [Full Text] [Related]  

  • 28. Disseminated coagulopathies and advanced malignancies.
    Fengler SA; Berenberg JL; Lee YT
    Am Surg; 1990 Jun; 56(6):335-8. PubMed ID: 2350105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost effectiveness and ease of administration of low molecular weight heparin in deep vein thrombosis.
    Teo CP; Lim HL; Kueh YK
    Thromb Haemost; 1994 Aug; 72(2):328-9. PubMed ID: 7831676
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Problems of oral anticoagulation in an adult with homozygous protein C deficiency and late onset of thrombosis.
    Pescatore P; Horellou HM; Conard J; Piffoux M; Van Dreden P; Ruskone-Fourmestraux A; Samama M
    Thromb Haemost; 1993 Apr; 69(4):311-5. PubMed ID: 8497841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consortium data: comparative efficacy of low molecular weight heparin and warfarin following total hip replacement.
    Colwell CW
    Orthopedics; 1995 Jul; 18 Suppl():21-3. PubMed ID: 7479422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated occurrence of skin necrosis twice following coumarin intake and subsequently during decrease of vitamin K dependent coagulation factors associated with cholestasis.
    Hofmann V; Frick PG
    Thromb Haemost; 1982 Dec; 48(3):245-6. PubMed ID: 7164013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of thrombophlebitis of the lower limbs in polyclinical practice].
    Serova EV
    Khirurgiia (Mosk); 1965 Sep; 41(9):64-8. PubMed ID: 5878999
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
    Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
    Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous warfarin as an alternative for anticoagulation.
    Gellatly RM
    Pharmacotherapy; 2007 Jun; 27(6):933-5. PubMed ID: 17542775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Updated review of oral anticoagulants resistance. A case report.
    Alloza JL
    Arch Farmacol Toxicol; 1984 Apr; 10(1):45-56. PubMed ID: 6508369
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of heparin and warfarin on antithrombin III.
    O'Brien JR; Etherington MD
    Lancet; 1977 Dec; 2(8050):1231. PubMed ID: 73931
    [No Abstract]   [Full Text] [Related]  

  • 40. Re: Webster K, Wilde J. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations. Br J Oral Maxillofac Surg 2000; 38: 124-126.
    Muthukrishnan A
    Br J Oral Maxillofac Surg; 2002 Jun; 40(3):266. PubMed ID: 12054729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.